Search research articles
Contact Us
Filters
Showing results (71-80 of 107) with videos related to
Page
of 11
Sort By:
JAMA
|
March 20, 1981
Successful treatment of naturally occurring influenza A/USSR/77 H1N1
L P Van Voris, R F Betts, F G Hayden, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 1994
Oral LY217896 for prevention of experimental influenza A virus infection and illness in humans
F G Hayden, A R Tunkel, J J Treanor, et al.
Antimicrobial Agents and Chemotherapy
|
August 1, 1987
Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds
B M Farr, E M Conner, R F Betts, et al.
JAMA
|
January 24, 1996
Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza
F G Hayden, J J Treanor, R F Betts, et al.
Transactions - American Society for Artificial Internal Organs
|
January 1, 1972
Shedding patterns of herpes simplex virus and cytomegalovirus among chronic dialysis patients
R F Betts, R G Douglas, R C Pabico, et al.
Journal of Medical Virology
|
October 1, 1988
Analysis of virus and host factors in a study of A/Peking/2/79 (H3N2) cold-adapted vaccine recombinant in which vaccine-associated illness occurred in normal volunteers
R F Betts, R G Douglas, H F Maassab, et al.
The American Review of Respiratory Disease
|
March 11, 1976
Evaluation of a temperature-sensitive influenza virus in elderly and chronically ill subjects
R G Douglas, D W Bentley, R F Betts, et al.
American Journal of Hematology
|
August 6, 1998
Ciprofloxacin plus piperacillin is an equally effective regimen for empiric therapy in febrile neutropenic patients compared with standard therapy
J J Griggs, E A Blair, J R Norton, et al.
The Journal of Infectious Diseases
|
December 1, 1988
Comparison of live, attenuated H1N1 and H3N2 cold-adapted and avian-human influenza A reassortant viruses and inactivated virus vaccine in adults
S D Sears, M L Clements, R F Betts, et al.
Vaccine
|
December 2, 1999
Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses
J J Treanor, K Kotloff, R F Betts, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 107) with videos related to
Sort By:
Page
of 11
JAMA
|
March 20, 1981
Successful treatment of naturally occurring influenza A/USSR/77 H1N1
L P Van Voris, R F Betts, F G Hayden, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 1994
Oral LY217896 for prevention of experimental influenza A virus infection and illness in humans
F G Hayden, A R Tunkel, J J Treanor, et al.
Antimicrobial Agents and Chemotherapy
|
August 1, 1987
Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds
B M Farr, E M Conner, R F Betts, et al.
JAMA
|
January 24, 1996
Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza
F G Hayden, J J Treanor, R F Betts, et al.
Transactions - American Society for Artificial Internal Organs
|
January 1, 1972
Shedding patterns of herpes simplex virus and cytomegalovirus among chronic dialysis patients
R F Betts, R G Douglas, R C Pabico, et al.
Journal of Medical Virology
|
October 1, 1988
Analysis of virus and host factors in a study of A/Peking/2/79 (H3N2) cold-adapted vaccine recombinant in which vaccine-associated illness occurred in normal volunteers
R F Betts, R G Douglas, H F Maassab, et al.
The American Review of Respiratory Disease
|
March 11, 1976
Evaluation of a temperature-sensitive influenza virus in elderly and chronically ill subjects
R G Douglas, D W Bentley, R F Betts, et al.
American Journal of Hematology
|
August 6, 1998
Ciprofloxacin plus piperacillin is an equally effective regimen for empiric therapy in febrile neutropenic patients compared with standard therapy
J J Griggs, E A Blair, J R Norton, et al.
The Journal of Infectious Diseases
|
December 1, 1988
Comparison of live, attenuated H1N1 and H3N2 cold-adapted and avian-human influenza A reassortant viruses and inactivated virus vaccine in adults
S D Sears, M L Clements, R F Betts, et al.
Vaccine
|
December 2, 1999
Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses
J J Treanor, K Kotloff, R F Betts, et al.
Page
of 11